Current state and perspectives of dendritic cell vaccination in cancer immunotherapy (Q36448084)

14 August 2017

1 reference

title

Current state and perspectives of dendritic cell vaccination in cancer immunotherapy (English)

1 reference

14 August 2017

1 reference

1 reference

Farkas A

1

1 reference

14 August 2017

Conrad C

2

1 reference

14 August 2017

Tonel G

3

1 reference

14 August 2017

Borbenyi Z

4

1 reference

14 August 2017

Kemeny L

5

1 reference

14 August 2017

Dobozy A

6

1 reference

14 August 2017

Nestle FO

7

1 reference

14 August 2017

language of work or name

1 reference

6 April 2006

1 reference

Skin Pharmacology and Physiology

14 August 2017

1 reference

14 August 2017

19

1 reference

14 August 2017

124-131

1 reference

14 August 2017

3

1 reference

Dendritic cells and the control of immunity

14 August 2017

1 reference

Immunobiology of dendritic cells

21 January 2018

1 reference

Mouse and human dendritic cell subtypes

21 January 2018

1 reference

Interleukin-12 and the regulation of innate resistance and adaptive immunity

21 January 2018

1 reference

Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer

21 January 2018

1 reference

Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma

21 January 2018

1 reference

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

21 January 2018

1 reference

Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells

21 January 2018

1 reference

Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo

21 January 2018

1 reference

Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation.

21 January 2018

1 reference

Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation

21 January 2018

1 reference

Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance

21 January 2018

1 reference

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

21 January 2018

1 reference

In vivo manipulation of dendritic cells overcomes tolerance to unmodified tumor-associated self antigens and induces potent antitumor immunity.

21 January 2018

1 reference

Plasmacytoid dendritic cells in immunity

21 January 2018

1 reference

IFN-α Skews Monocyte Differentiation into Toll-Like Receptor 7-Expressing Dendritic Cells with Potent Functional Activities

21 January 2018

1 reference

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

21 January 2018

1 reference

Synergy between tumor immunotherapy and antiangiogenic therapy

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000092592

1 reference

14 August 2017

1 reference